A new endowed professorship will support the work of Geisel professor James Sargent, a leading expert in the relationship between mass media and risky behavior among children and adolescents.
Post Tagged with: "Norris Cotton Cancer Center"
Dartmouth researchers have found that early exposure to the ultraviolet radiation lamps used for indoor tanning is related to an increased risk of developing basal cell carcinomas (BCC) at a young age.
A recent study evaluating HER2 testing in a large cohort of women with breast cancer found important limitations in the conventional way HER2 testing is performed in the U.S. and internationally.
Mark A. Israel, MD, director of the Norris Cotton Cancer Center (NCCC), has been named the inaugural holder of the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth.
A Dartmouth researcher has found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor 1 (IGF1) receptor.
In a recent study, offering support services soon after a patient’s diagnosis reduced depression among caregivers.
New research by an international group of scientists confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations.
James D. Gorham, MD, PhD, an associate professor of pathology and of microbiology and immunology, has been named the first associate director for education at Dartmouth-Hitchcock Norris Cotton Cancer Center.
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. When specific mutations for a cancer type are identified, patients can be treated with chemotherapy or other targeted agents that work on those mutations.
Dartmouth will serve as a Lead Academic Participating Site in the National Cancer Institute’s (NCI) new National Clinical Trials Network (NCTN), which is intended to improve the speed and efficiency of conducting cancer clinical trials.